4basebio AG (4BSB) NPV
4Basebio AG, formerly Expedeon AG, is a Germany-based biotechnology company. The Company develops and markets molecular-diagnostic technologies, such as in field of deoxyribonucleic acid (DNA) amplification and sequencing. The Company's solutions are used in drug discovery research and diagnostic product development and include TruePrime whole genome amplification technology, the Lightning-Link antibody labeling technology, the CaptSure single-step antibody capture technology, the RunBlue Bis Tris gels for electrophoresis, and colloidal gold nanoparticles for point of care lateral flow assays, such as pregnancy testing, among others. In addition, the Company offers custom services, such as antibody and particle conjugation, as well as delivers bulk orders. The Company operates through subsidiaries in Germany, Spain, Australia, Singapore, the United Kingdom and the United States.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.